All peptides.

A pentadecapeptide fragment derived from a protective protein found in gastric juice. Widely studied in preclinical models of tissue repair, gut mucosal integrity, and angiogenic signaling.

A synthetic peptide corresponding to an active region of Thymosin β4, an actin-binding protein involved in cell migration and wound repair in preclinical models.

A naturally occurring copper-binding tripeptide studied extensively in models of fibroblast activity, collagen synthesis, and skin regeneration.

A tetrasubstituted analog of GHRH(1-29) engineered for metabolic stability. Widely used in preclinical research on pulsatile growth hormone release.

A pentapeptide growth hormone secretagogue receptor agonist developed as a research tool for selective GH release without significant cortisol or prolactin elevation in published preclinical models.

A synthetic analog of human GHRH(1-44) stabilized by N-terminal trans-3-hexenoic acid. Approved as Egrifta for HIV-associated lipodystrophy and widely studied in visceral adipose tissue research.

A long-acting analog of human glucagon-like peptide-1 with extensive published literature across glycemic, weight, and cardiovascular research endpoints.

A synthetic 39-amino-acid peptide engineered as a unimolecular dual agonist at the GIP and GLP-1 receptors. Extensive recent literature in glycemic and weight research.

A next-generation synthetic peptide engineered as a unimolecular triple agonist at the GIP, GLP-1, and glucagon receptors. Actively studied in Phase 2/3 trials and an object of intense research interest.

A 16-amino-acid peptide encoded within the mitochondrial 12S rRNA region, studied as a metabolic signaling molecule and modulator of AMPK-dependent pathways.

A short tetrapeptide first characterized in Russian longevity research as a putative bioregulator of pineal function and telomerase activity in preclinical models.

A cyclic heptapeptide analog of α-MSH acting at central melanocortin receptors. Approved as Vyleesi® for hypoactive sexual desire disorder; widely studied in melanocortin pathway research.